Chinese biopharma Mabwell raises $278m in Series A round led by Shiyu Capital

Chinese biopharma Mabwell raises $278m in Series A round led by Shiyu Capital

Source: Laurynas Mereckas/Unsplash

29 April, 2020

biopharmaceutical Mabwell BioScience Shiyu Investment

Printed by Unregistered user on Sat, 12 Jul 2025 07:20:26 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

China’s Allist Pharma raises $171m Series A led by Shiyu Capital

Chinese PE firm Shiyu Capital raises $473m for second RMB fund

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims